Anika Therapeutics, Inc.: capex
| Value | {"amount": 2732000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ec22f10d-c496-424e-a4ce-fe4298e94dba
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-21-005594Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/capex/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ec22f10d-c496-424e-a4ce-fe4298e94dba
History
- no predecessors — first report